TMEM94

TMEM94 (ERMA) is an endoplasmic reticulum-localized, multi-pass transmembrane P-type ATPase that mediates Mg2+ uptake into the ER, establishing the ER as a major intracellular Mg2+ store (PMID:38513662). It carries cytosolic actuator, nucleotide, and phosphorylation domains characteristic of P-type ATPases, uniquely combined with a GMN motif, and uses a conserved active-site tyrosine for Mg2+ binding and catalysis in a manner shared with prokaryotic Mg2+ ATPases (PMID:38513662). ERMA does not act alone: it forms an ER Mg2+ transport complex with TUSC3, which is required for ERMA-mediated Mg2+ uptake, and loss of either partner depletes ER Mg2+ and activates the PERK-eIF2α ER stress pathway, producing synaptic dysfunction and cognitive deficits that are rescued by magnesium supplementation (PMID:41203647). Disruption of ERMA-dependent Mg2+ homeostasis impairs cardiomyocyte Ca2+ cycling and cardiac function (PMID:38513662), and complete loss is embryonic lethal in mice with craniofacial, cardiac, and neuronal migration defects, with bi-allelic truncating variants abolishing TMEM94 expression in patients (PMID:30526868).

1. 2018 Medium

   Before function was known, the question was whether TMEM94 was essential and disease-relevant; demonstrating embryonic lethality and human developmental phenotypes established it as a critical developmental gene.

   Evidence CRISPR/Cas9 mouse knockout with developmental phenotyping plus transcriptome profiling of patient-derived cells carrying bi-allelic truncating variants

   PMID:30526868

   Open questions at the time

   • No molecular activity or transport function identified at this stage
   • Subcellular role described as nuclear, not yet resolved to the ER
   • Mechanism connecting gene loss to craniofacial/cardiac/neuronal defects unknown
2. 2024 High

   The central mechanistic question — what TMEM94 actually does — was answered by showing it is an ER-resident P-type ATPase that pumps Mg2+ into the ER via a conserved active-site tyrosine, defining the ER as a refillable Mg2+ compartment.

   Evidence AlphaFold2 structural prediction, active-site tyrosine mutagenesis, cellular Mg2+ transport assays, and loss-of-function in mouse Erma+/- and human iPSC-cardiomyocytes

   PMID:38513662

   Open questions at the time

   • No experimental high-resolution structure of the transporter
   • Stoichiometry and counter-ion/coupling of the transport cycle not defined
   • Co-factor requirement for transport not yet identified at this stage
3. 2024 Medium

   Linking ER Mg2+ transport to organ physiology, ERMA haploinsufficiency was shown to disrupt cardiomyocyte Ca2+ cycling and cardiac function, connecting ER Mg2+ homeostasis to excitation-contraction coupling.

   Evidence Mouse Erma+/- haploinsufficiency model with cardiomyocyte Ca2+ cycling and cardiac function measurements

   PMID:38513662

   Open questions at the time

   • Mechanistic link between ER Mg2+ and Ca2+ handling not molecularly resolved
   • Single lab, single phenotypic axis
   • Whether cardiac defect reflects transport loss specifically vs broader ER dysfunction unclear
4. 2025 High

   The question of how ERMA achieves transport was advanced by identifying TUSC3 as an obligate ER complex partner, tying ERMA/TUSC3 Mg2+ depletion to PERK-eIF2α stress, synaptic and cognitive deficits reversible by Mg2+.

   Evidence TUSC3-ERMA co-complex analysis, TUSC3 knockout mouse, ER Mg2+ measurements, PERK-eIF2α assays, patient fibroblasts, and magnesium supplementation rescue

   PMID:41203647

   Open questions at the time

   • Structural basis of the ERMA-TUSC3 interaction not defined
   • Whether TUSC3 modulates catalysis, targeting, or Mg2+ delivery unresolved
   • Direct binding interface and stoichiometry of the complex unknown

• How ER Mg2+ levels are sensed and how ERMA activity is regulated to coordinate cardiac, synaptic, and developmental demands remains unresolved.
• No regulatory inputs or post-translational control of ERMA characterized
• Mechanism connecting ER Mg2+ depletion to specific developmental defects unmapped
• No experimental transporter structure or defined transport cycle